Clinical Trial Update: Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Exploratory Phase 1/2 clinical study evaluating apatinib plus SHR-1210 in advanced gastric cancer or hepatocellular carcinoma; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• SHR-1210 (camrelizumab)

Snippet

Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Conditions: Gastric Cancer, Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN